Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

Huang, CS; Yu, AL; Tseng, LM; Chow, LWC; Hou, MF; Hurvitz, SA; Schwab, RB; Murray, JL; Chang, HK; Chang, HT; Chen, SC; Kim, SB; Hung, JT; Ueng, SH; Lee, SH; Chen, CC; Rugo, HS

Rugo, HS (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (2):

Abstract

Purpose This randomized, double-blind, placebo-controlled, parallel-group, phase II trial assessed the efficacy and safety of adagloxad simolenin (OBI......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索